| Bioactivity | DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated drugs[1][2]. |
| Name | DSPE-PEG-Maleimide |
| CAS | 474922-22-0 |
| Formula | (C2H4O)nC51H92N1O13P.H3N |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Schnorenberg MR, et, al. Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester Hydrolysis. ACS Omega. 2018 Oct 31;3(10):14144-14150. [2]. Huwyler J, et, al. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14164-9. |
DSPE-PEG-Maleimide
CAS: 474922-22-0 F: (C2H4O)nC51H92N1O13P.H3N W:
DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide exten
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.